top of page

Enhancing Synergy in Research: Directorate of Research and Development of the Indonesian National Military-Land Force (TNI AD) Health Center Visits DLBS Cikarang

  • Writer: Corry Saputra
    Corry Saputra
  • May 31, 2023
  • 2 min read

Updated: Jan 14



Dexa Group welcomed a visit and knowledge-sharing session with the Directorate of Research and Development of the Indonesian Army Health Center (Pengembangan Pusat Kesehatan TNI AD (Puskesad)) to Dexa Laboratories of Biomolecular Sciences (DLBS) on Monday, May 29, 2023. This visit strengthened the synergy between Dexa Group and the TNI AD Health Center in health research.


The Director of Research and Development of the TNI AD Health Center, Colonel Ckm Dr. Jusron Iriawan Sp, attended the visit.PD, along with representatives from the Bio Vaccine Institute (Labiovak), the Army Pharmacy Institute (Lafiad), and the Military Health Institute (Lakesmil) of Puskesad. From Dexa Group, the delegation included Mrs. Evi Dwi Nofiarny, Head of Corporate Quality Audit, PV & QRM of PT Dexa Medica, and Mr. Laurentius Haryanto, Group Research Innovation & Invention Manager of DLBS.


Mrs. Evi Dwi Nofiarny highlighted that one of Dexa Group's roles as a pharmaceutical industry leader is to support government efforts to achieve independence in pharmaceutical raw materials. This is accomplished through the research and development of Indonesian Indigenous Modern Medicines (Obat Modern Asli Indonesia (OMAI)) at DLBS. She also expressed gratitude for Puskesad's support in collaborating on research to improve public health.


"Dexa Group is committed to continuously conducting research and ensuring product safety. Training collaboration with the TNI AD Health Center can be pursued by inviting DLBS researchers to be speakers in scientific discussions organized by Puskesad," said Mrs. Evi.


In the same session, the Director of Research and Development of the TNI AD Health Center, Colonel Ckm Dr. Jusron Iriawan, Sp.PD, expressed his admiration for the research facilities at DLBS. He commended Dexa Group for its efforts in researching and developing medicines to improve the health of the Indonesian population.


"It is hoped that future collaboration will continue, potentially in the form of training sessions conducted by DLBS researchers for Puskesad researchers," concluded Colonel Jusron.

bottom of page